Author Page for Chiara Zagni

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

Tio2/Loofah-Halloysite Bio-Hybrid Composites as Efficient Systems for the Vocs Removal

Number of pages: 18 Posted: 18 Aug 2023

Vincenzo Patamia, Roberto Fiorenza, Stefano Andrea Balsamo, Chiara Zagni, Sarai Agustin-Salazar, Salvatore Scirè, Giuseppe Floresta and Antonio Rescifina

University of Catania, University of Catania, University of Catania, University of Catania, National Research Council (CNR) - Institute for Polymers, Composites and Biomaterials, University of Catania, University of Catania and University of Catania

Downloads 39

Abstract:

Repurposing FDA-approved drugs as SIRT3-binding candidates for Ataxia–Telangiectasia: An integrated virtual screening, molecular dynamics, and SPR study

Number of pages: 18 Posted: 26 Apr 2026

Rocco Buccheri, Alessia Distefano, Chiara Zagni, Giuseppe Grasso, Anna Piperno and Antonio Rescifina

University of Catania, University of Catania, University of Catania, University of Catania, University of Messina and University of Catania

Downloads 27

Abstract:

An Integrated in Silico and SPR-based Workflow Identifies FDA-Approved Drugs as Previously Unrecognized SIRT3 Binders

Number of pages: 20 Posted: 27 May 2026

Rocco Buccheri, Alessia Distefano, Chiara Zagni, Giuseppe Grasso, Anna Piperno and Antonio Rescifina

University of Catania, University of Catania, University of Catania, University of Catania, University of Messina and University of Catania

Downloads 15

Chiara Zagni

University of Catania

3

81

0

Scholarly Papers (3)

Tio2/Loofah-Halloysite Bio-Hybrid Composites as Efficient Systems for the Vocs Removal

Abstract:

Repurposing FDA-approved drugs as SIRT3-binding candidates for Ataxia–Telangiectasia: An integrated virtual screening, molecular dynamics, and SPR study

Abstract:

An Integrated in Silico and SPR-based Workflow Identifies FDA-Approved Drugs as Previously Unrecognized SIRT3 Binders

Abstract: